Encompass Health Corp/ US29261A1007 /
| 31.10.2024 20:58:25 | Diff. -1,63 | Volumen | Geld21:25:00 | Brief21:25:00 | Marktkapitalisierung | Dividendenr. | KGV |
|---|---|---|---|---|---|---|---|
| 99,73USD | -1,61% | 19.521 Umsatz: 1,04 Mio. |
-Geld Vol: - | -Brief Vol: - | 10,01 Mrd.USD | 0,60% | 28,34 |
Aktiva
| 2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sachanlagen | 1.391,8000 | 1.517,1000 | 1.634,8000 | 1.959,3000 | 2.206,6000 | ||||||
| Immaterielle Vermögensgegenstände | 411,3000 | 403,1000 | 443,4000 | 476,3000 | 431,3000 | ||||||
| Finanzanlagen | - | - | - | - | - | ||||||
| Anlagevermögen | - | 4.191,5000 | 4.512,9000 | 5.324,9000 | 5.497,3000 | ||||||
| Vorräte | - | - | - | - | - | ||||||
| Forderungen | 443,8000 | 472,1000 | 467,7000 | 506,1000 | 572,8000 | ||||||
| Liquide Mitteln | 40,5000 | 54,4000 | 69,2000 | 94,8000 | 224 | ||||||
| Umlaufvermögen | 654,5000 | 702,2000 | 662,1000 | 755,8000 | 948,6000 | ||||||
| Aktiva, gesamt | 4.681,9000 | 4.893,7000 | 5.175 | 6.080,7000 | 6.445,9000 | ||||||
Passiva
| 2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Verbindlichkeiten aus Lieferungen und Leistungen | 68,3000 | 78,4000 | 90 | 94,6000 | 115 | ||||||
| Langfristige Schulden | 2.979,3000 | 2.545,4000 | 2.478,6000 | 3.023,3000 | 3.250,6000 | ||||||
| Verbindlichkeiten gegenüber Kreditinstituten | 2.979,3000 | 2.545,4000 | 2.478,6000 | 3.023,3000 | 3.250,6000 | ||||||
| Rückstellungen | - | - | - | - | 51,8000 | ||||||
| Verbindlichkeiten | 3.753,2000 | 3.469,1000 | 3.618 | 4.387,6000 | 4.475,9000 | ||||||
| Gezeichnetes Kapital | 1,1000 | 1,1000 | 1,1000 | 1,1000 | 1,1000 | ||||||
| Eigenkapital | 928,7000 | 1.424,6000 | 1.557 | 1.693,1000 | 1.970 | ||||||
| Minderheitenanteile | 192,8000 | 242,9000 | 280,3000 | 340,9000 | 382 | ||||||
| Passiva, gesamt | 4.681,9000 | 4.893,7000 | 5.175 | 6.080,7000 | 6.445,9000 | ||||||
Gewinn- und Verlustrechnung
| 2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 3.707,2000 | 3.971,4000 | 4.277,3000 | 4.605 | 4.644,4000 | ||||||
| Abschreibungen (Gesamt) | 172,6000 | 183,8000 | 199,7000 | 218,7000 | 243 | ||||||
| Betriebsergebnis | - | - | - | - | - | ||||||
| Zinsergebnis | 172,1000 | 154,4000 | 147,3000 | 159,7000 | 184,2000 | ||||||
| Ergebnis vor Steuern | 482 | 496,4000 | 493,2000 | 562,3000 | 472,6000 | ||||||
| Ertragsteuern | 163,9000 | 160,6000 | 118,9000 | 115,9000 | 103,8000 | ||||||
| Gewinnanteil Minderheitsgesellschafter | -70,5000 | -79,1000 | -83,1000 | -87,1000 | -84,6000 | ||||||
| Konzernjahresüberschuss | 247,6000 | 256,3000 | 292,3000 | 358,7000 | 284,2000 | ||||||
Pro Aktie
Cash Flow
| 2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow aus laufender Geschäftstätigkeit | 605,5000 | 657,2000 | 762,4000 | 635,3000 | 704,7000 | ||||||
| Cash Flow aus Investitionstätigkeit | -245 | -284,5000 | -424,5000 | -657,4000 | -407,5000 | ||||||
| Cash Flow aus Finanzierungstätigkeit | -381,6000 | -358,8000 | -321,2000 | 48,2000 | -145,9000 | ||||||
| Veränderung der liquiden Mittel | -21,1000 | 13,9000 | 16,7000 | 26,1000 | 151,3000 | ||||||
| Anzahl der Mitarbeiter | 35.710 | 29.370 | 30.060 | 31.570 | 43.178 | ||||||
